Skip to main content
Log in

Berberine attenuates mitochondrial dysfunction by inducing autophagic flux in myocardial hypoxia/reoxygenation injury

  • Original Paper
  • Published:
Cell Stress and Chaperones Aims and scope

Abstract

Berberine (BBR) is routinely prescribed in many Asian countries to treat diarrhea. Evidence from both animal and clinical investigations suggests that BBR exerts diverse pharmacological activities, including antidiabetic, antineoplastic, antihypertensive, and antiatherosclerotic effects. This study aimed to explore the cardioprotective mechanisms of BBR and to elucidate the modulations between autophagy and mitochondrial function during hypoxia/reoxygenation (H/R) in H9c2 cells. The degree of autophagic flux was assessed by pretreating H9c2 cells with BBR prior to H/R exposure and measuring the expression levels of Beclin-1 and green fluorescent protein (GFP)-labeled LC3B fusion proteins as well as the LC3II/LC3I ratio. The mitochondrial membrane potential (△Ψm) in H9c2 cells was evaluated by detecting rhodamine-123 fluorescence using flow cytometry. The results revealed that pretreatment with BBR upregulated autophagic flux and protected against the loss of the △Ψm in H9c2 cells subjected to H/R. We conclude that BBR attenuates mitochondrial dysfunction by inducing autophagic flux.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

ATP:

adenosine triphosphate

AVs:

autophagic vacuoles

GFP-LC3B:

green fluorescent protein-labeled LC3B

H/R:

hypoxia/reoxygenation

I/R:

ischemia/reperfusion

LC3:

microtubule-associated protein 1 light chain 3

TEM:

transmission electron microscopy

△Ψm:

mitochondrial membrane potential

References

Download references

Funding

This study was supported by the National Natural Science Foundation of China (project number: U1704167, to Dr. Cao), Henan Provincial Science and Technology Project (project numbers: 182102310525 (Dr. Cao), 172102310063 (Dr. Hao), and 202102310088 (Dr. Li)), Joint Construction Project of Henan Medical Science and Technology Tackling Plan (project number: 2018020475 (Dr. Zhu)), Henan Medical Science and Technology Tackling Plan Provincial-ministerial Coconstruction Project (project number: SB201902033 (Dr. Cao)), and Key scientific research projects of colleges and Universities of Henan Province (project number: 20A320086 (Dr. Li)).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Chuanyu Gao or Li Li.

Ethics declarations

All experiments were performed in accordance with the Animals (Scientific Procedures) Act 1986 and following approval from the Ethical Review Board.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, N., Cao, X., Hao, P. et al. Berberine attenuates mitochondrial dysfunction by inducing autophagic flux in myocardial hypoxia/reoxygenation injury. Cell Stress and Chaperones 25, 417–426 (2020). https://doi.org/10.1007/s12192-020-01081-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12192-020-01081-5

Keywords

Navigation